William Gramig | Stern Investor Relations |
Derek Chalmers | President and Chief Executive Officer |
Christopher Posner | Incoming CEO |
Thomas Reilly | Chief Financial Officer |
Jessica Fye | JPMorgan |
Chris Howerton | Jefferies |
David Amsellem | Piper Sandler |
Annabel Samimy | Stifel |
Good afternoon and welcome to Cara Therapeutics’ Third Quarter 2021 Financial Results Conference Call. All participants are now in a listen-only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Cara’s request. I would now like to turn the call over to the Cara team.